• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-15

  The reference study shows that selected kinase inhibitors can both suppress p38α catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Biochemical measurements and X-ray structures connect this effect to stabilization of a phosphatase-accessible activation-loop conformation, suggesting a framework for designing more durable and selective kinase inhibitors.

• Anisomycin Workflows for JNK Signaling Studies

  2026-08-14

  Anisomycin provides a practical pharmacological entry point for separating early JNK signaling from later cell death phenotypes. This guide covers concentration and timing screens, cancer-apoptosis applications, neurobiology extensions, and controls that prevent stress-response data from being overinterpreted.

• Olaparib: A G4–PARP Combination Framework

  2026-08-14

  Olaparib and AZD2281 are examined as mechanistic tools for connecting PARP inhibition with the BLM G-quadruplex–STAT1 axis. This framework helps researchers design more informative DNA damage response assays, combination studies, and tumor radiosensitization experiments.

• Astrocytic GAT-3 Controls Dentate Gyrus Memory

  2026-08-13

  Shen and colleagues show that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus synaptic transmission through presynaptic GluN2B-containing NMDARs. The study connects this glial pathway to contextual fear memory and provides a mechanistic framework for synaptic transmission research and related in vitro neurotransmission assays.

• Anisomycin, JNK Signaling, and Translational Strategy

  2026-08-13

  Anisomycin is more than a cytotoxicity reagent: it is a mechanistic JNK agonist that can help translational researchers connect stress signaling, apoptosis, and experimental decision-making. This article places its cancer biology applications alongside emerging lessons from social memory research while clearly separating established evidence from forward-looking hypotheses.

• Acacetin, Mitophagy, and Pyroptosis in IVDD

  2026-08-12

  A 2025 Phytomedicine study identifies an acacetin-mediated MAPK1/HMOX1 pathway through which Duhuo Jisheng decoction enhances mitophagy and suppresses nucleus pulposus cell pyroptosis in intervertebral disc degeneration. Its integrated chemical, cellular, and animal-model design provides a useful framework for connecting traditional medicine components with mitochondrial quality control and inflammatory cell death.

• Adefovir (GS-0393) in HBV Research

  2026-08-12

  Adefovir combines a mechanistically clear HBV polymerase readout with a useful OAT1 transporter application, enabling antiviral and renal-disposition workflows from one research tool. This guide covers dose-response design, aqueous handling, transporter kinetics, and interpretation of hypophosphatemia-related translational signals.

• Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-08-11

  The 2024 preprint identifies kinase inhibitors that do more than suppress p38α catalytic signaling: they also accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Biochemical measurements and X-ray structures suggest that inhibitor-stabilized activation-loop conformations expose the phosphatase substrate, providing a framework for designing kinase inhibitors that promote pathway shutdown through two coordinated mechanisms.

• BH3-Mimetics Target Apoptotic Vulnerability in GBM

  2026-08-11

  Koessinger and colleagues show that glioblastoma, including patient-derived stem-like cells, is unusually dependent on anti-apoptotic BCL-XL and MCL-1. Their data support sequential BH3-mimetic targeting as a way to exploit apoptotic priming and generate anti-tumor responses in experimental GBM models.

• Anisomycin and JNK: A Memory Assay Framework

  2026-08-10

  Anisomycin is more than a JNK agonist for apoptosis studies: it can serve as a pathway-level perturbation in carefully controlled investigations of synaptic memory maintenance. This article connects JNK signaling to the neuroligin 1 proteolysis mechanism while defining the controls needed to avoid confusing pathway activation with causal proof.

• RWJ 67657: Practical p38α/β Workflows

  2026-08-09

  RWJ 67657, also known as JNJ-3026582, combines selective p38α/β targeting with measurable suppression of inflammatory cytokine output. This guide translates its pharmacology into reproducible cell-based assays, translational study designs, and troubleshooting strategies for inflammatory disease research.

• Cy3 NHS ester (non-sulfonated) Workflow

  2026-08-08

  Cy3 NHS ester (non-sulfonated) provides an orange-emitting NHS ester for labeling primary amino groups on proteins, peptides, and oligonucleotides when an organic co-solvent is acceptable. It is not water-soluble, so it should not be selected for strictly aqueous labeling workflows or for applications requiring long-term storage of prepared dye solutions.

• JXY, TLR4, and M1 Polarization in Colitis-Linked CRC

  2026-08-07

  Liu et al. report that Jiedu Xiaozheng Yin (JXY) suppresses colitis-associated colorectal cancer by shifting macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines an orthotopic mouse model with RAW264.7 macrophage assays to connect tumor burden, tissue pathology, macrophage markers, phagocytosis, and pathway antagonism.

• IBDV VP3 Protein Drives IRF7 Degradation to Enhance Viral Re

  2026-08-07

  This study elucidates how Infectious bursal disease virus (IBDV) leverages its VP3 protein to suppress the host's IRF7-mediated interferon response, accelerating viral replication. The findings reveal a mechanism of immune evasion via proteasome-dependent IRF7 degradation, with implications for antiviral research and the study of ubiquitin-proteasome system inhibition.

• Safe DNA Gel Stain: Practical Guidelines for Sensitive Nucle

  2026-08-06

  Safe DNA Gel Stain (SKU A8743) offers a safer, high-sensitivity alternative to ethidium bromide for DNA and RNA staining in agarose and acrylamide gels. It minimizes mutagenic exposure and supports blue-light imaging, making it best suited for general molecular biology workflows but less effective for low molecular weight DNA (<200 bp). Use is not recommended for clinical or diagnostic applications.

16695 records 1/1113 page Next 12345 下5页 Last page